Edition:
United Kingdom

Gensight Biologics SA (SIGHT.PA)

SIGHT.PA on Paris Stock Exchange

1.43EUR
4:35pm BST
Change (% chg)

€-0.01 (-0.83%)
Prev Close
€1.44
Open
€1.44
Day's High
€1.48
Day's Low
€1.43
Volume
82,794
Avg. Vol
266,078
52-wk High
€5.28
52-wk Low
€1.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.882
Jun '18 0.00 -0.481
FY 2017 Dec '17 0.00 -0.507
Jun '17 0.00 -0.622
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 3.50 7.00 0.00 3.50
Year Ending Dec-20 2 16.40 24.00 8.80 13.90
Earnings (per share)
Year Ending Dec-19 2 -0.94 -0.94 -0.94 -1.12
Year Ending Dec-20 2 -0.76 -0.74 -0.79 -1.02
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.29 32.55
P/E High - Last 5 Yrs. -- 147.69 48.11
P/E Low - Last 5 Yrs. -- 47.94 23.41
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.50 8.44
Price to Book (MRQ) 1.81 10.13 5.27
Price to Tangible Book (MRQ) 1.86 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.72 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.71
Payout Ratio(TTM) -- 7.02 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.03 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 49.04 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.31 48.19
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 14.47 3.57 2.98
LT Debt to Equity (MRQ) 4.08 18.62 11.35
Total Debt to Equity (MRQ) 4.08 31.29 16.04
Interest Coverage (TTM) -- -43.11 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.28 52.36
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.91 12.41
Operating Margin (TTM) -- -184.92 5.62
Operating Margin - 5 Yr. Avg. -- -127.40 8.00
Pre-Tax Margin (TTM) -- -175.61 4.64
Pre-Tax Margin - 5 Yr. Avg. -- -133.19 8.28
Net Profit Margin (TTM) -- -182.33 1.37
Net Profit Margin - 5 Yr. Avg. -- -137.59 4.69
Effective Tax Rate (TTM) -- 22.46 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,652,628 819,624,485
Net Income/Employee (TTM) -- 513,404 92,776,848
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.42
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.37 10.65
Return on Assets - 5 Yr. Avg. -- 5.47 11.77
Return on Investment (TTM) -- 8.90 13.82
Return on Investment - 5 Yr. Avg. -- 6.78 15.32
Return on Equity (TTM) -- 10.04 15.24
Return on Equity - 5 Yr. Avg. -- 8.36 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -11.84 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gensight Biologics SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.40 -2.30 99 99
13 Week 6.24 1.98 99 95
26 Week -29.22 -32.19 47 97
52 Week -39.53 -49.45 49 70
YTD -34.06 -40.19 41 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 48.38%
# of Holders: 15
Total Shares Held: 13,896,829
3 Mo. Net Change: -1,232,999
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 1
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.